In this paper, the enantiomers of (±)-1, previously studied as α1 and 5-HT1A ligands, were prepared both by resolution of the racemate and asymmetric synthesis. The enantiomeric purity and absolute configuration were determined by means of HPLC and polarimetric analysis. Enantiomers were evaluated for in vitro 5-HT1A and α1 receptor affinity by binding and functional assays. Results indicate that the two enantiomers are almost equally potent at 5-HT1A and α1 receptor systems and, contrary to WB 4101, the stereoselectivity is poor. As further support to these experimental findings, molecular docking studies on the two enantiomers of (±)-1 have been performed and a comparison with those obtained for 5-HT1A potent agonist (R)-flesinoxan and α1d antagonist (S)-WB 4101 has been drawn.

Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent α1and 5-HT1Areceptor ligand: an in vitro and computational study / Franchini, Silvia; Baraldi, Anna Maria; Sorbi, Claudia; Pellati, Federica; Cichero, Elena; Battisti, UMBERTO MARIA; Angeli, Piero; Cilia, Antonio; Brasili, Livio. - In: MEDCHEMCOMM. - ISSN 2040-2503. - STAMPA. - 6:4(2015), pp. 677-690. [10.1039/C4MD00484A]

Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent α1and 5-HT1Areceptor ligand: an in vitro and computational study

FRANCHINI, Silvia;BARALDI, Anna Maria;SORBI, Claudia;PELLATI, Federica;BATTISTI, UMBERTO MARIA;BRASILI, Livio
2015

Abstract

In this paper, the enantiomers of (±)-1, previously studied as α1 and 5-HT1A ligands, were prepared both by resolution of the racemate and asymmetric synthesis. The enantiomeric purity and absolute configuration were determined by means of HPLC and polarimetric analysis. Enantiomers were evaluated for in vitro 5-HT1A and α1 receptor affinity by binding and functional assays. Results indicate that the two enantiomers are almost equally potent at 5-HT1A and α1 receptor systems and, contrary to WB 4101, the stereoselectivity is poor. As further support to these experimental findings, molecular docking studies on the two enantiomers of (±)-1 have been performed and a comparison with those obtained for 5-HT1A potent agonist (R)-flesinoxan and α1d antagonist (S)-WB 4101 has been drawn.
23-dic-2014
6
4
677
690
Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent α1and 5-HT1Areceptor ligand: an in vitro and computational study / Franchini, Silvia; Baraldi, Anna Maria; Sorbi, Claudia; Pellati, Federica; Cichero, Elena; Battisti, UMBERTO MARIA; Angeli, Piero; Cilia, Antonio; Brasili, Livio. - In: MEDCHEMCOMM. - ISSN 2040-2503. - STAMPA. - 6:4(2015), pp. 677-690. [10.1039/C4MD00484A]
Franchini, Silvia; Baraldi, Anna Maria; Sorbi, Claudia; Pellati, Federica; Cichero, Elena; Battisti, UMBERTO MARIA; Angeli, Piero; Cilia, Antonio; Brasili, Livio
File in questo prodotto:
File Dimensione Formato  
MedChemComm_2015_enantiomers.pdf

non disponibili

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 3.71 MB
Formato Adobe PDF
3.71 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1062767
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact